Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Other Non-Current Liabilities: 2022-2025

Historic Other Non-Current Liabilities for Orchestra BioMed Holdings (OBIO) over the last 2 years, with Sep 2025 value amounting to $248,000.

  • Orchestra BioMed Holdings' Other Non-Current Liabilities was N/A to $248,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $248,000, marking a year-over-year change of. This contributed to the annual value of $40,000 for FY2024, which is N/A change from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Other Non-Current Liabilities stood at $248,000 for Q3 2025, which was up 31.22% from $189,000 recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Other Non-Current Liabilities ranged from a high of $2.4 million in Q1 2023 and a low of $40,000 during Q4 2024.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $213,000 (2023), whereas its average is $489,714.